Skip to main content
Equibles

Farther Finance Advisors, LLC

Position in RVMD — Revolution Medicines, Inc.

CIK 1992825 SAN FRANCISCO, CA
Back to RVMD Full portfolio

Position in RVMD

as of Sep 30, 2026 · filed Oct 8, 2026
Position Value
$995,100
+$602,374 QoQ
Shares Held
4,848
+131.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1
of 17 holders
Holding Since
Dec 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in RVMD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Sep 30, 2026

Farther Finance Advisors, LLC holds $27,307,338 across 327 Biotechnology names. RVMD ranks #7 (3.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 9,471 $4,951,533
2 MRNA
Moderna, Inc.
 17,622 $3,393,468
3 HALO
Halozyme Therapeutics, Inc.
 11,074 $1,222,569
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,534 $1,163,186
5 INCY
Incyte Corp
 9,256 $1,123,215
6 EXEL
Exelixis, Inc.
 18,290 $1,068,318
7 RVMD
Revolution Medicines, Inc.
This page 		4,848 $995,100
8 ARWR
Arrowhead Pharmaceuticals, Inc.
 12,147 $795,021

All Filings in RVMD

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-09-30 $995,100 4,848
2026-06-30 $392,726 2,097
2026-03-31 $94,138 968
2025-12-31 $59,817 751
2025-09-30 $24,237 519
2025-06-30 $18,836 512
2025-03-31 $15,204 430
2024-12-31 $89,710 2,051
2024-09-30 $19,863 438
2024-06-30 $15,834 408
2024-03-31 $11,312 351
2023-12-31 $10,382 362